Home › NDC Lookup › RxCUI directory › RxCUI 2391560

1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng] — RxCUI 2391560

RxNorm drug concept · Semantic branded drug
RxCUI 2391560 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2391560
Official name1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as1 ML Enspryng 120 MG/ML Prefilled Syringe; Enspryng 120 MG in 1 ML Prefilled Syringe; Enspryng 120 MG per 1 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped4
Reported Medicaid activity (SDUD)462 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

🕸️ Concept Web — How 1 ML satralizumab-mwge 120 MG/ML Prefilled Syrin... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe [Enspryng] RxCUI 2391560

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Satralizumab 2391541
    • Satralizumab-mwge 2391551
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Enspryng 2391556
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Satralizumab Prefilled Syringe 2391554
    • Satralizumab-mwge Prefilled Syringe 2647002
    • Satralizumab Injectable Product 2391553
    • Satralizumab-mwge Injectable Product 2662264
    • Satralizumab Prefilled Syringe [Enspryng] 2391558
    • Satralizumab-mwge Prefilled Syringe [Enspryng] 2654921
    • Enspryng Injectable Product 2391559
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 1 ML satralizumab-mwge 120 MG/ML Prefilled Syringe SCD · 2391555
  • Satralizumab-mwge 120 MG/ML SCDC · 2391552
  • Satralizumab Prefilled Syringe SCDF · 2391554
  • Satralizumab-mwge Prefilled Syringe SCDFP · 2647002
  • Satralizumab Injectable Product SCDG · 2391553
  • Satralizumab-mwge Injectable Product SCDGP · 2662264

Brand-Name Concepts

  • Satralizumab-mwge 120 MG/ML [Enspryng] SBDC · 2391557
  • Satralizumab Prefilled Syringe [Enspryng] SBDF · 2391558
  • Satralizumab-mwge Prefilled Syringe [Enspryng] SBDFP · 2654921
  • Enspryng Injectable Product SBDG · 2391559
  • Enspryng BN · 2391556

📦 FDA Products & Package NDCs

1 product · 4 package NDCs
4 package NDCs map to RxCUI 2391560 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50242-0007-01 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-01) / 1 mL in 1 S... Enspryng Genentech, Inc. 2020-08-14
50242-0007-33 1 SYRINGE in 1 CARTON (50242-007-33) / 1 mL in 1 SYRINGE Enspryng Genentech, Inc. 2026-06-10
50242-0007-55 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-55) / 1 mL in 1 S... Enspryng Genentech, Inc. 2026-06-10
50242-0007-86 1 SYRINGE, PLASTIC in 1 CARTON (50242-007-86) / 1 mL in 1 S... Enspryng Genentech, Inc. 2021-08-13
Observed labelers: Genentech, Inc. (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.